Our story

How our NDD approach can help the clear need in the pharma industry


What is Network-Driven Drug Discovery ("NDD")?

The science behind our NDD approach


What is Genome-Associated Interaction Networks ("GAINs")?

How we use our network biology expertise and technology to generate actionable insights from genomic data.

GAINs video thumbnail.png

Network-Driven Drug Discovery: An Application of In-Memory Distributed Processing

Talk by Jonny Wray, head of discovery informatics, at the In-Memory Computing Summit Europe 2018


FANTASI: FAst NeTwork Analysis in Silicon

Project submission, for which e-therapeutics is industrial driver, and first prize winner in the PhD category of the Xilinx Open Hardware Competition 2018.


Edison TV interview with Ray Barlow, CEO

Dr Ray Barlow, CEO of e-Therapeutics, provides an overview of the company, and outlines the output of its recent strategic review and its focus moving forward.


Proactive Investors interview with Ray Barlow, CEO

Ray Barlow, chief executive of e-Therapeutics plc (LON:ETX) caught up with Proactive to update on developments at the drug developer.